European Journal of Nuclear Medicine and Molecular Imaging

Title Publication Date Language Citations
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.02014/12/02English1,938
FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.02009/11/14English904
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer2014/11/20English744
Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use2000/03/07691
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer2013/09/27English669
PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions2012/11/24English655
Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease2005/03/04English578
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.02017/03/10English523
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours2013/02/07English470
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-22020/02/28English459
Guidelines for radioiodine therapy of differentiated thyroid cancer2008/08/01English433
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 22009/10/17English394
F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients2016/11/26English380
Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients2017/05/12English378
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study2003/08/01378
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology2005/05/21English363
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting2003/04/18English358
Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis2012/10/13English340
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data2001/10/31English339
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours2007/05/23English335
Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region2002/08/08English334
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer2020/03/28English333
Characterization of PET/CT images using texture analysis: the past, the present… any future?2016/06/06English319
Quantification of myocardial blood flow with 82Rb dynamic PET imaging2007/07/07English310
Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.02018/12/05English310
Myocardial perfusion scintigraphy: the evidence2003/11/25English307
Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers2008/10/01English304
Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI2003/04/04English303
Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer1998/09/01295
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease2009/01/14English294